XORTX Therapeutics Inc Financial Overview
XORTX Therapeutics Inc's market cap is currently C$5.40M. The company's EPS TTM is C$-0.1777840987; its P/E ratio is -1.18; XORTX Therapeutics Inc is scheduled to report earnings on November 15, 2025, and the estimated EPS forecast is C$-0.23. See an overview of income statement, balance sheet, and cash flow financials.
